Ashok Leyland announces resumption of Plant Operations

Ashok Leyland announces resumption of Plant Operations       “With the relaxation of the lockdown, we have resumed operations in all our plants across the Country, after obtaining necessary approvals from the relevant authorities. In accordance with the stated guidelines as given by the Ministry of Home Affairs (MHA) and the relevant local authorities, we shall be ensuring all the necessary health and safety protocols in our facilities, for all stakeholders. We will gradually ramp up production across facilities after taking into consideration the Work in Progress (WIP) that…

Read More

Cipla enters into a licensing agreement With Gilead to expand access to COVID-19 treatment

Cipla enters into a licensing agreement With Gilead to expand access to COVID-19 treatment     Cipla Limited  today announced that it has signed a non-exclusive licensing agreement with Gilead Sciences, Inc. for the manufacturing and distribution of the investigational medicine Remdesivir, which has been issued an Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) to treat COVID-19 patients. This agreement is part of Cipla’s efforts to enhance global access to lifesaving treatments for patients affected by the pandemic. As part of the agreement, Cipla will…

Read More